Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The...
Manufacturing of biopharmaceutical products such as monoclonal antibodies (mAbs) or vaccines is a complex process. The complexity is due to the heterogeneity typical for...
03.09.2015
- In September 2014, Merck announced the €13.1 billion acquisition of Sigma-Aldrich, which by mid-August has received antitrust clearance from all relevant jurisdictions including...
